Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease

International Journal of Cardiovascular Imaging

Volumn 24, Issue 6, 2008, Pages 597-607

  Bohl, Steffen ^a   Wassmuth, Ralf ^a   Abdel Aty, Hassan ^a   Rudolph, André ^a   Messroghli, Daniel ^a   Dietz, Rainer ^a   Schulz Menger, Jeanette ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiomyopathies; Fibrosis; Gadolinium dTPA; Magnetic resonance imaging; Non ischemic heart disease

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AORTA STENOSIS; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE INJURY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; RETROSPECTIVE STUDY; SARCOIDOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS;

CONTRAST MEDIA; GADOLINIUM DTPA; HEART DISEASES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 48949117160     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-008-9300-x     Document Type: Article

References (39)

1. Wagner A, Mahrholdt H, Holly TA et al (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet 361:374-379
2. Bello D, Fieno DS, Kim RJ et al (2005) Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45:1104-1108
3. Abdel-Aty H, Boye P, Zagrosek A et al (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: Comparison of different approaches. J Am Coll Cardiol 45:1815-1822
4. Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156-2164
5. McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54-59
6. Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology. Circulation 109:1250-1258
7. Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977-1985
8. Nazarian S, Bluemke DA, Lardo AC et al (2005) Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112:2821-2825
9. Gottlieb I, Macedo R, Bluemke DA, Lima JA (2006) Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: Current applications and future perspectives. Heart Fail Rev 11:313-323
10. Jackson E, Bellenger N, Seddon M et al (2007) Ischaemic and non-ischaemic cardiomyopathies-cardiac MRI appearances with delayed enhancement. Clin Radiol 62:395-403
11. Vogel-Claussen J, Rochitte CE, Wu KC et al (2006) Delayed enhancement MR imaging: Utility in myocardial assessment. Radiographics 26:795-810
12. Mahrholdt H, Wagner A, Judd RM et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461-1474
13. Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 93:841-842
14. Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539-542
15. Carr DH, Brown J, Bydder GM et al (1984) Gadolinium-DTPA as a contrast agent in MRI: Initial clinical experience in 20 patients. AJR Am J Roentgenol 143:215-224
16. Kim RJ, Chen EL, Lima JA, Judd RM (1996) Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94:3318-3326
17. Aso H, Takeda K, Ito T et al (1998) Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol 33:22-32
18. Messroghli DR, Radjenovic A, Kozerke S et al (2004) Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52:141-146
19. Mahrholdt H, Wagner A, Deluigi CC et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581-1590
20. Lenghaus C, Studdert MJ (1984) Acute and chronic viral myocarditis. Acute diffuse nonsuppurative myocarditis and residual myocardial scarring following infection with canine parvovirus. Am J Pathol 115:316-319
21. Bultmann BD, Klingel K, Sotlar K et al (2003) Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34:92-95
22. Magnani JW, Danik HJ, Dec GW Jr, DiSalvo TG (2006) Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J 151:463-470
23. McCarthy RE III, Boehmer JP, Hruban RH et al (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690-695
24. Cooper LT Jr, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis-natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336:1860-1866
25. Knaapen P, van Dockum WG, Bondarenko O et al (2005) Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J Nucl Med 46:923-929
26. Moon JC, Mogensen J, Elliott PM et al (2005) Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 91:1036-1040
27. Debl K, Djavidani B, Buchner S et al (2006) Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: Visualisation of focal fibrosis. Heart 92:1447-1451
28. Blyth KG, Groenning BA, Martin TN et al (2005) Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 26:1993-1999
29. Kuribayashi T, Roberts WC (1992) Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 70:1333-1340
30. Maehashi N, Yokota Y, Takarada A et al (1991) The role of myocarditis and myocardial fibrosis in dilated cardiomyopathy. Analysis of 28 necropsy cases. Jpn Heart J 32:1-15
31. Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: Analysis of 152 necropsy patients. Am J Cardiol 60:1340-1355
32. Pauschinger M, Knopf D, Petschauer S et al (1999) Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 99:2750-2756
33. Kawai S, Okada R (1990) Interstitial cell infiltrate and myocardial fibrosis in dilated cardiomyopathy: A special type of cardiomegaly corresponding to sequelae of myocarditis. Heart Vessels 5:230-236
34. Cothran LHE, Sandler H (1973) An analysis of left ventricular dimensional changes in conscious animals. Dewy Publication, Washington DC, pp 553-565
35. Petersen SE, Kardos A, Neubauer S (2005) Subendocardial and papillary muscle involvement in a patient with Churg-Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance. Heart 91:e9
36. Mukherjee B, Chir B, Moon JC et al (2004) Endomyocardial fibrosis in Churg-Strauss syndrome. Clin Cardiol 27:21
37. Hein S, Arnon E, Kostin S et al (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107:984-991
38. Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 128:1629-1637
39. Knockaert DC (2007) Cardiac involvement in systemic inflammatory diseases. Eur Heart J 15:1797-1804